| Name | Title | Contact Details |
|---|---|---|
Anne-Marie Tucker |
Chief Technology Officer | Profile |
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
ONYX Healthcare USA is a Brea, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Calhoun Vision is focused on developing vision correction technologies for post-cataract surgery patients.
The massage franchise started in 2004 and has grown to more than 120 Retreats throughout North America by providing personalized wellness treatment options through therapeutic massage and skincare services. Massage Heights is a family-owned massage and wellness franchise dedicated to elevating the lives of others by providing Members and Guests with professional, affordable and resort-quality massage, skincare and wellness services.
The Bright Spot for Health is a Wichita, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.